Intensity Therapeutics, Inc. Provides Update on the Phase 2 Presurgical Triple-Negative Breast Cancer INVINCIBLE-4 Study [Yahoo! Finance]
Intensity Therapeutics, Inc. Provides Update on the Phase 2 Presurgical Triple-Negative Breast Cancer INVINCIBLE-4 Study
Intensity Therapeutics regains compliance with Nasdaq's minimum bid price requirement [Seeking Alpha]
Intensity Therapeutics Regains Compliance with Nasdaq's Minimum Bid Price Requirement [Yahoo! Finance]
Intensity Therapeutics Regains Compliance with Nasdaq's Minimum Bid Price Requirement